Integrin antagonists are effective and safe for Crohn&rsquo;s disease: A meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 15

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Apr 21, 2015; 21(15): 4744-4749
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4744

Full Size Figure Download Figure

Figure 1 Flow diagram of the studies identified.

Citation: Ge WS, Fan JG. Integrin antagonists are effective and safe for Crohn’s disease: A meta-analysis. World J Gastroenterol 2015; 21(15): 4744-4749
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4744.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i15.4744

Ge WS, Fan JG. Integrin antagonists are effective and safe for Crohn’s disease: A meta-analysis. World J Gastroenterol 2015; 21(15): 4744-4749 [PMID: 25914486 DOI: 10.3748/wjg.v21.i15.4744]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.